Ghent University Academic Bibliography

Journal Article
A1
open access

Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer : a systematic review

Eva Hulstaert (UGent) , Annelien Morlion (UGent) , Keren Levanon, Jo Vandesompele (UGent) and Pieter Mestdagh (UGent)

(2021) GYNECOLOGIC ONCOLOGY. 160(2). p.633-642

Add to list

Journal Article
A1
open access

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

S. W. Vrede, W. J. van Weelden, N. C. M. Visser, J. Bulten, L. J. M. van der Putten, Koen Van de Vijver (UGent) , M. Santacana, E. Colas, A. Gil-Moreno, C. P. Moiola, et al.

(2021) GYNECOLOGIC ONCOLOGY. 161(3). p.787-794

Add to list

Increased incidence of ovarian cancer in both endometriosis and adenomyopsis

M. Hermens, A.M. Van Altena, J. Bulten, Hubertus van Vliet (UGent) , A.G. Siebers and R.L.M. Bekkers

(2021) GYNECOLOGIC ONCOLOGY. 162(3). p.735-740

Add to list

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo (UGent) , Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Kathia De Man (UGent) , Eline Naert (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , et al.

(2020) GYNECOLOGIC ONCOLOGY. 159(2). p.335-343

Add to list

The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review

M. Timmermans, O. van der Hel, G.S. Sonke, Koen Van de Vijver (UGent) , M.A. van der Aa and R.F. Kruitwagen

(2019) Gynecologic Oncology. 153(2). p.445-451

Add to list

The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer

J.O.A.M. van Baal, Koen Van de Vijver (UGent) , M.D. Algera, M.A. van der Aa, G.S. Sonke, W.J. van Driel, G.G. Kenter, F.C. Amant and C.A.R. Lok

(2019) Gynecologic Oncology. 153(3). p.562-567

Add to list

Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer

M Timmermans, MA van der Aa, R, I Lalisang, PO Witteveen, Koen Van de Vijver (UGent) , RF Kruitwagen and GS Sonke

(2018) GYNECOLOGIC ONCOLOGY. 150(3). p.446-450

Add to list

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle, Frederieke H van der Baan, Andrew Berchuck, Sharon E Johnatty, Katja K Aben, Bjarni A Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L Andrulis, Hoda Anton-Culver, et al.

(2016) GYNECOLOGIC ONCOLOGY. 141(2). p.386-401

Add to list

Mucinous borderline tumours of the ovary and the appendix : a retrospective study and overview of the literature

M Kleppe, J Bruls, T Van Gorp, L Massuger, BFM Slangen, Koen Van de Vijver (UGent) , AJ Kruse and RFPM Kruitvvagen

(2014) GYNECOLOGIC ONCOLOGY. 133(2). p.155-158

Add to list

Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? : a large multi-institutional analysis

Quratulain Ahmed, Yaser Hussein, Kinda Hayek, Sudeshna Bandyopadhyay, Assaad Semaan, Fadi Abdul-Karim, Zaid Al-Wahab, Adnan R Munkarah, Mohamed A Elshaikh, Baraa Alosh, et al.

(2014) GYNECOLOGIC ONCOLOGY. 132(2). p.372-376

Academic Bibliography

Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer : a systematic review

Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Increased incidence of ovarian cancer in both endometriosis and adenomyopsis

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review

The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer

Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Mucinous borderline tumours of the ovary and the appendix : a retrospective study and overview of the literature

Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? : a large multi-institutional analysis

Contents

Support

Contact